BioCentury
ARTICLE | Distillery Therapeutics

Infectious disease

November 2, 2016 11:11 PM UTC

Non-human primate studies suggest a polyvalent inactivated human rhinovirus (HRV) vaccine could help prevent HRV infection. The vaccine consisted of 50 formalin-inactivated HRV strains expressing a range of differing HRV capsids, plus an alum adjuvant. In rhesus macaques, the vaccine elicited neutralizing antibodies against 49 out of the 50 viral strains. Next steps include generating a vaccine formulation that includes the 83 known strains of HRV type A...

BCIQ Company Profiles

Emory University

BCIQ Target Profiles

HRV capsid